173 related articles for article (PubMed ID: 16023752)
1. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles.
Bunjes H; Koch MH
J Control Release; 2005 Oct; 107(2):229-43. PubMed ID: 16023752
[TBL] [Abstract][Full Text] [Related]
2. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
3. Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers.
Kuntsche J; Koch MH; Drechsler M; Bunjes H
Colloids Surf B Biointerfaces; 2005 Jul; 44(1):25-35. PubMed ID: 15990283
[TBL] [Abstract][Full Text] [Related]
4. Visualizing the structure of triglyceride nanoparticles in different crystal modifications.
Bunjes H; Steiniger F; Richter W
Langmuir; 2007 Mar; 23(7):4005-11. PubMed ID: 17316032
[TBL] [Abstract][Full Text] [Related]
5. Stability of the Metastable α-Polymorph in Solid Triglyceride Drug-Carrier Nanoparticles.
Joseph S; Rappolt M; Schoenitz M; Huzhalska V; Augustin W; Scholl S; Bunjes H
Langmuir; 2015 Jun; 31(24):6663-74. PubMed ID: 26030714
[TBL] [Abstract][Full Text] [Related]
6. Thermal analysis of the crystallization and melting behavior of lipid matrices and lipid nanoparticles containing high amounts of lecithin.
Schubert MA; Schicke BC; Müller-Goymann CC
Int J Pharm; 2005 Jul; 298(1):242-54. PubMed ID: 15905050
[TBL] [Abstract][Full Text] [Related]
7. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
Schubert MA; Harms M; Müller-Goymann CC
Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
[TBL] [Abstract][Full Text] [Related]
8. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
[TBL] [Abstract][Full Text] [Related]
9. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
Windbergs M; Strachan CJ; Kleinebudde P
Eur J Pharm Biopharm; 2009 Jan; 71(1):80-7. PubMed ID: 18588976
[TBL] [Abstract][Full Text] [Related]
10. Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles.
Kuntsche J; Koch MH; Steiniger F; Bunjes H
J Colloid Interface Sci; 2010 Oct; 350(1):229-39. PubMed ID: 20619846
[TBL] [Abstract][Full Text] [Related]
11. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
12. Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles.
Kuntsche J; Bunjes H
Eur J Pharm Biopharm; 2007 Nov; 67(3):612-20. PubMed ID: 17574399
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles.
Illing A; Unruh T
Int J Pharm; 2004 Oct; 284(1-2):123-31. PubMed ID: 15454303
[TBL] [Abstract][Full Text] [Related]
14. Temperature scanning ultrasonic velocity study of complex thermal transformations in solid lipid nanoparticles.
Awad TS; Helgason T; Kristbergsson K; Weiss J; Decker EA; McClements DJ
Langmuir; 2008 Nov; 24(22):12779-84. PubMed ID: 18925768
[TBL] [Abstract][Full Text] [Related]
15. Influence of emulsifiers on the crystallization of solid lipid nanoparticles.
Bunjes H; Koch MH; Westesen K
J Pharm Sci; 2003 Jul; 92(7):1509-20. PubMed ID: 12820155
[TBL] [Abstract][Full Text] [Related]
16. Dialkylphosphatidylcholine and egg yolk lecithin for emulsification of various triglycerides.
Nii T; Ishii F
Colloids Surf B Biointerfaces; 2005 Apr; 41(4):305-11. PubMed ID: 15748826
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of nitrendipine solid lipid nanoparticles.
Manjunath K; Venkateswarlu V; Hussain A
Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
Venkateswarlu V; Manjunath K
J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
[TBL] [Abstract][Full Text] [Related]
20. The physical state of lipid nanoparticles influences their effect on in vitro cell viability.
Petersen S; Steiniger F; Fischer D; Fahr A; Bunjes H
Eur J Pharm Biopharm; 2011 Sep; 79(1):150-61. PubMed ID: 21458564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
